Yearly Archives: 2025
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12).
Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025
New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement.
CLENE ANNOUNCES STATISTICALLY SIGNIFICANT ALS BIOMARKER RESULTS SUPPORTING ACCELERATED APPROVAL PATHWAY FOR CNM-AU8®
FDA recommended biomarker analyses show statistically significant reductions in NfL and GFAP in participants treated with CNM-Au8.
Canary Speech Earns Microsoft Solutions Partner: Healthcare AI Certified Software Designation
Prestigious recognition validates Canary Speech’s leadership in healthcare-focused AI voice technology and its proven interoperability with the Microsoft Cloud
bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia
bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia
PolarityBio Completes Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers
PolarityBio thanks the clinical trial sites and, most importantly, the participants, for making this milestone in DFU biologic therapy development possible
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants
Milestone enables immediate production of SiN/PEEK custom devices
5 Trends to Expect From Vocal Biomarker Technology in 2026
By Henry O’Connell, CEO and co-founder of Canary Speech Vocal biomarker data has come a long way in a short amount of time. No longer relegated to the pages of science fiction, the power of the human voice to assist in diagnoses is established fact. Providers already possess technological platforms that make informed care […]
Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever
SALT LAKE CITY, UT (Business Wire) – Seek Labs, a biotechnology company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the publication of a peer-reviewed paper in Viruses (MDPI), revealing the first successful use of a CRISPR-based therapeutic to treat African Swine Fever Virus (ASFV) in pigs. The […]
Owlet and Locus Health Partner to Seamlessly Deliver Infant Health Data into Remote Patient Monitoring Programs
This first-of-its-kind infant care collaboration for Owlet enables clinicians to access Owlet’s data through Locus Health’s platform, enhancing visibility, improving care continuity, and supporting families after hospital discharge. LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces a partnership with Locus Health, a leader in […]
ARUP Advocates for the RESULTS Act To Protect Patient Access to Critical Laboratory Testing Services
SALT LAKE CITY, November 19, 2025— With a deadline approaching on January 31, 2026, ARUP Laboratories has joined other clinical laboratories in advocating for passage of the federal Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, which would block looming cuts in payments for lab testing services, relieve labs of burdensome reporting, […]
Recap: 2025 Mayer Brown Utah Life Sciences Summit
The 2025 BioUtah Utah Life Sciences Summit (ULSS) took place November 12 at the Hilton Salt Lake City Center, featuring keynote speakers, awards, educational sessions, networking opportunities, and the signing of a Memorandum of Understanding (MOU) with the Korea Health Industry Development Institute. With 650 registrants, this year’s Summit was the biggest yet. Jefferson Moss, […]
